Science Explorer Back to mapMap
Discussion
Company · Monrovia · United States

Xencor (United States)

World rank, all time
#34,402
of 34,923
Rank in United States
#7,223
of 7,310
Research works
140
▼ 14% vs 2018-21
Citations
7k
50.1 per fractional work
Top-10% rate
10.4%
all institutions 10.0%
vs its own fields
1.07×
1.00× is exactly expected
Open access
40%
world 40%
International
15%
world 18%

Which fields of science does Xencor (United States) work in?

In 2022-now, 58% of research at Xencor (United States) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (58%), Immunology and Microbiology (24%), Biochemistry, Genetics and Molecular Biology (8%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 58.2% of its workMedicine: 15 fractional works · 58.2% of its workOncology: 7 fractional works · 27.4% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 17.3% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 2.0% of its workPathology and Forensic Medicine: 0 fractional works · 1.6% of its workEpidemiology: 0 fractional works · 1.3% of its workHepatology: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.0% of its workSurgery: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.2% of its workOphthalmology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workLife Sciences: 8 fractional works · 32.9% of its workImmunology and Microbiology: 6 fractional works · 23.8% of its workImmunology: 6 fractional works · 23.7% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 7.9% of its workGenetics: 1 fractional works · 3.2% of its workMolecular Biology: 1 fractional works · 2.9% of its workBiotechnology: 0 fractional works · 1.3% of its workCell Biology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.5% of its workPhysical Sciences: 1 fractional works · 4.8% of its workComputer Science: 1 fractional works · 3.4% of its workInformation Systems: 0 fractional works · 2.0% of its workHardware and Architecture: 0 fractional works · 0.7% of its workSoftware: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.7% of its workStatistics and Probability: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.7% of its workSocial Sciences: 1 fractional works · 4.1% of its workArts and Humanities: 1 fractional works · 3.9% of its workArcheology: 1 fractional works · 2.6% of its workHistory: 0 fractional works · 1.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workALL ITS WORKXencor (UnitedStates)26fractional works, 2022-now
Life Sciences33%Physical Sciences5%Health Sciences58%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine1558.2%
    1. Immunology and Microbiology623.8%
    2. Biochemistry, Genetics and Molecular Biology27.9%
    3. Neuroscience00.7%
    4. Pharmacology, Toxicology and Pharmaceutics00.5%
    1. Computer Science13.4%
    2. Mathematics00.7%
    3. Chemistry00.7%
    1. Arts and Humanities13.9%
    2. Economics, Econometrics and Finance00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.49× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 23.63× its world share, 6 worksImmunology and Micro…Neuroscience: 0.40× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.45× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.42× its world share, 0 worksChemistryComputer Science: 0.44× its world share, 1 worksComputer ScienceMathematics: 0.61× its world share, 0 worksMathematicsMedicine: 3.03× its world share, 15 worksMedicineArts and Humanities: 1.35× its world share, 1 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.08× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 23.6×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Immunology and Microbiology23.63×6 works
  2. Medicine3.03×15 works
  3. Biochemistry, Genetics and Molecular Biology1.49×2 works
  4. Pharmacology, Toxicology and Pharmaceutics1.45×0 works
  5. Arts and Humanities1.35×1 works
  6. Mathematics0.61×0 works
  7. Computer Science0.44×1 works
  8. Chemistry0.42×0 works
  9. Neuroscience0.40×0 works
  10. Economics, Econometrics and Finance0.08×0 works

Who are the top researchers at Xencor (United States)?

Ranked on the quality score, Sher Karki, Greg A. Lazar and Omid Vafa lead among researchers whose main affiliation is Xencor (United States).

  1. 1 Sher Karki United States · #128,014 worldwide 6.8k citations · 141 works
  2. 2 Greg A. Lazar United States · #340,361 worldwide 5k citations · 87 works
  3. 3 Omid Vafa United States · #364,246 worldwide 4.4k citations · 35 works
  4. 4 David E. Szymkowski United States · #388,636 worldwide 4.6k citations · 93 works
  5. 5 John R. Desjarlais United States · #409,450 worldwide 6k citations · 187 works
  6. 6 David F. Carmichael United States · #616,817 worldwide 3.2k citations · 27 works
  7. 7 Michael Hedvat United States · #771,322 worldwide 2k citations · 51 works
  8. 8 Bassil I. Dahiyat United States · #886,236 worldwide 4k citations · 23 works
  9. 9 Rumana Rashid United States · #891,808 worldwide 2.8k citations · 146 works
  10. 10 Umesh S. Muchhal United States · #905,707 worldwide 2.6k citations · 108 works
All ranked researchers at Xencor (United States)

What are the most cited papers from Xencor (United States)?

The most cited paper from Xencor (United States) is "Engineered antibody Fc variants with enhanced effector function" (Greg A. Lazar, Wei Dang, Sher Karki et al., 2006), with 804 citations. Next come "Enhanced antibody half-life improves in vivo activity" (664) and "JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes" (405).

Most cited papers
#PaperReleasedCitations
1 Engineered antibody Fc variants with enhanced effector function Greg A. Lazar, Wei Dang, Sher Karki et al. · Proceedings of the National Academy of Sciences Open access 6 Mar 2006 804
2 Enhanced antibody half-life improves in vivo activity Jonathan Zalevsky, Aaron K. Chamberlain, Holly M. Horton et al. · Nature Biotechnology Open access 17 Jan 2010 664
3 JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes Matthew T. Nguyen, Hiroaki Satoh, Svetlana Favelyukis et al. · Journal of Biological Chemistry Open access 6 Aug 2005 405
4 Characterizing biological products and assessing comparability following manufacturing changes Arthur J. Chirino, Anthony R. Mire‐Sluis · Nature Biotechnology Nov 2004 364
5 Blocking Soluble Tumor Necrosis Factor Signaling with Dominant-Negative Tumor Necrosis Factor Inhibitor Attenuates Loss of Dopaminergic Neurons in Models of Parkinson's Disease Melissa K. McCoy, Terina N. Martinez, Kelly A. Ruhn et al. · Journal of Neuroscience Open access 13 Sep 2006 362
All 60 most cited papers, with filters and sorting

Which keywords describe research at Xencor (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Lymphoma, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Glycosylation and Monoclonal Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Cancer Immunotherapy7▲ 177×3 topics
  2. Immunotherapy5▲ 29×5 topics
  3. Lymphoma5▲ 125×2 topics
  4. Tumor Regression5▲ 177×2 topics
  5. CAR T Cells5▲ 253×1 topic
  6. Chimeric Antigen Receptor5▲ 253×1 topic
  7. Glycosylation4▲ 142×2 topics
  8. Monoclonal Antibodies4▲ 166×2 topics
  9. Fc Receptors4▲ 260×1 topic
  10. Therapeutic Antibodies4▲ 204×1 topic
  11. NK Cell Recognition3▲ 165×1 topic
  12. Natural Killer Cells3▲ 165×1 topic
  13. Tumor Microenvironment2▲ 20×3 topics
  14. Innate Immunity2▲ 27×2 topics
  15. Antigen Presentation2▲ 89×1 topic
  16. Dendritic Cells2▲ 91×1 topic
  17. Immune Checkpoint Blockade2▲ 70×1 topic
  18. Immunity2▲ 20×2 topics
  19. PD-1 and PD-L12▲ 70×1 topic

Which research topics does Xencor (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.

  1. 1 CAR-T cell therapy research Oncology 5 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
  3. 3 Immune Cell Function and Interaction Immunology 3 works
  4. 4 Immunotherapy and Immune Responses Immunology 2 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 2 works
  6. 6 Inflammatory Bowel Disease Genetics 0 works
  7. 7 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works
  8. 8 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  10. 10 T-cell and B-cell Immunology Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.0%not open60.0%

World: 40% of research is openly available.

with international co-authors14.7%domestic only85.3%

World: 18% is written across borders.

How has Xencor (United States)'s research output changed?

Output in 2022-2025 was 14% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Xencor (United States) as a percentage of every work published that year, 0.00011% in 2024.

still counting0.00020%0.00040%0.00060%Xencor (United States)0.000028% in 20251990200020102020

Fractional works of Xencor (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Monrovia

All research institutions in Monrovia

Share Xencor (United States)'s ranking

Xencor (United States) on Science Explorer

A card with Xencor (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Xencor (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.